Skip to content

Real Time Early Warning Model and Mobile Medical Assistant System for the Impact of Air Pollution on AECOPD Disease

Real Time Early Warning Model and Mobile Medical Assistant System for the Impact of Air Pollution on Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04960410
Enrollment
56
Registered
2021-07-13
Start date
2017-01-01
Completion date
2018-12-30
Last updated
2021-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

Objective to establish a real-time early warning model of acute exacerbation of chronic obstructive pulmonary disease (COPD) caused by air pollution, and develop the corresponding mobile medical assistant system. Through the cross fusion of existing information technology and medical research results, an auxiliary medical system is formed for information recording, tracking tools, early warning model and clinical diagnosis of patients with COPD.

Detailed description

Objective to establish a real-time early warning model of acute exacerbation of chronic obstructive pulmonary disease (COPD) caused by air pollution, and develop the corresponding mobile medical assistant system. Through the cross fusion of existing information technology and medical research results, an auxiliary medical system is formed for information recording, tracking tools, early warning model and clinical diagnosis of patients with COPD.

Interventions

COMBINATION_PRODUCTTypes and exposure of different air pollutants

Types and exposure of different air pollutants in COPD patients' living and working environment

Sponsors

Beihang University
CollaboratorOTHER
Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years

Inclusion criteria

* Patients aged \> 40 and \< 80 years with post-bronchodilator FEV1/ forced vital capacity (FVC) \< 0.7 and percentage predicted of FEV1\>30%, who were no exacerbation of symptoms in the 6 weeks preceding the study, were included in the study.

Exclusion criteria

* Patients who were diagnosed with other chronic respiratory diseases, including bronchial asthma, bronchiectasis and lung abscess. * Patients with near-terminal illness, congestive heart failure (NYHA III-IV), or cannot record CAT score timely were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Frequency of acute exacerbations1 year incidence rateFrequency of acute exacerbations

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026